Midday Report: Biodesix (BDSX) Shares Down on June 21

Equities Staff  |

Shares of Biodesix Inc (NASDAQ: BDSX) fell 7.22% Tuesday.

As of 11:48:12 est, Biodesix is currently sitting at $1.35 and dropped $0.105  per share.

Biodesix has moved 1.69% over the last 30 days and has moved YTD 72.50% based on the most recent close.

The company expects its next earnings on 2022-08-09.

For technical charts, analysis, and more on Biodesix visit the company profile.

About Biodesix Inc

Biodesix, Inc. operates as a biotechnology company. The Company offers non-small cell lung cancer pretreatment serum tests and laboratory testing. Biodesix provides diagnostic tools and equipment for blood and tissue analysis in the United States.

To get more information on Biodesix Inc and to follow the company's latest updates, you can visit the company's profile page here: Biodesix Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade

Market Movers

Sponsored Financial Content